Mullins Kevin Michael 4
4 · LifeStance Health Group, Inc. · Filed Mar 17, 2023
Insider Transaction Report
Form 4
Mullins Kevin Michael
Chief Development Officer
Transactions
- Sale
Common Stock
2023-03-15$6.11/sh−200$1,222→ 5,653,552 total - Sale
Common Stock
2023-03-16$6.14/sh−43,705$268,349→ 5,609,847 total
Footnotes (2)
- [F1]The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.
- [F2]The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $6.11 to $6.23 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.